Obesity
Showing NaN - NaN of 116
Breast Cancer, Obesity Trial in Dallas (Doxorubicin, Cyclophosphamide)
Completed
- Breast Cancer
- Obesity
-
Dallas, TexasUniversity of Texas Southwestern
Jul 24, 2018
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Birmingham, Alabama
- +225 more
Dec 20, 2017
Type 2 Diabetes, Obesity Trial in Dallas (Liraglutide, Saline)
Completed
- Type 2 Diabetes Mellitus
- Obesity
-
Dallas, TexasUT Southwestern
Dec 15, 2017
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Vestavia Hills, Alabama
- +160 more
Dec 6, 2017
Role of Pancreatic Triglyceride Content in Beta-cell Function
Completed
- Obesity
- Type 2 Diabetes
- No intervention planned.
-
Dallas, TexasUT Southwestern Medical Center
Nov 29, 2017
Changes in Ectopic Fat Following Surgically Induced Weight Loss
Completed
- Obesity
- Type 2 Diabetes
-
Dallas, TexasUniversity of Texas Southwestern
Nov 17, 2017
Obesity, Type 2 Diabetes Trial in Dallas (pioglitazone, )
Completed
- Obesity
- Type 2 Diabetes
- pioglitazone
- placebo
-
Dallas, TexasUT Southwestern Medical Center
Nov 14, 2017
Metabolism and Nutrition Disorder, Obesity Trial in Canada, United States (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Goodyear, Arizona
- +36 more
Sep 29, 2017
Metabolism and Nutrition Disorder, Obesity, Obstructive Sleep Apnoea Trial in Canada, United States (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- +2 more
- liraglutide
- placebo
-
Glendale, California
- +41 more
Sep 29, 2017
Obesity, Rhinitis, Rhinitis, Allergic Trial in Dallas (dietary supplement, other, device)
Terminated
- Obesity
- +11 more
- Vitamin A
- +11 more
-
Dallas, TexasVerifomics, LLC
Sep 27, 2017
Obesity Trial in Dallas (Vevazz LED)
Completed
- Obesity
- Vevazz LED
-
Dallas, TexasVevazz, LLC
Aug 3, 2017
Obesity, Pharmacokinetics, MRSA Trial in Dallas (Sulfamethoxazole/trimethoprim)
Completed
- Obesity
- +4 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
May 17, 2017
Obesity, Cardiovascular Diseases Trial in United States (Naltrexone HCl/Bupropion HCl ER, Placebo)
Terminated
- Obesity
- Cardiovascular Diseases
- Naltrexone HCl/Bupropion HCl ER
- Placebo
-
Alexander City, Alabama
- +138 more
Feb 21, 2017
Obesity, Fungal Infection Trial in Dallas (Caspofungin)
Completed
- Obesity
- Fungal Infection
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 21, 2016
Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)
Terminated
- Type 2 Diabetes
- Obesity
- EndoBarrier
- Sham Procedure
-
Birmingham, Alabama
- +24 more
Dec 2, 2016
Obesity Trial in United States (Transoral Suturing, Sham Endoscopy)
Terminated
- Obesity
- Transoral Suturing
- Sham Endoscopy
-
Denver, Colorado
- +9 more
Aug 12, 2016
Obesity, Leprosy, Tuberculosis Trial in Dallas (Dapsone)
Completed
- Obesity
- +2 more
-
Dallas, TexasUniversity of Texas Southwestern
Jun 9, 2016
Obesity Trial in United States (Placebo, Pramlintide and Metreleptin)
Completed
- Obesity
- Placebo
- Pramlintide and Metreleptin
-
Birmingham, Alabama
- +32 more
Mar 26, 2015
Overweight, Obesity Trial in United States (pramlintide acetate, metreleptin, -P)
Completed
- Overweight
- Obesity
- pramlintide acetate
- +3 more
-
Birmingham, Alabama
- +35 more
Mar 26, 2015
Obesity, Overweight, Diabetes, Type 2 Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/ day, Placebo, Ancillary
Completed
- Obesity
- +2 more
- Naltrexone SR 32 mg/bupropion SR 360 mg/ day
- +2 more
-
Fairhope, Alabama
- +52 more
Nov 18, 2014
Obesity, Overweight Trial in United States (Naltrexone SR 16 mg/Bupropion SR 360 mg /day, Naltrexone SR 32 mg/Bupropion SR 360
Completed
- Obesity
- Overweight
- Naltrexone SR 16 mg/Bupropion SR 360 mg /day
- +3 more
-
Birmingham, Alabama
- +33 more
Nov 18, 2014